ArticlePharmacological research2025

Telmisartan reverses hepatic steatosis via PCK1 upregulation: A novel PPAR-independent mechanism in experimental models of MASLD.

Roger Bentanachs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.